Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Neonatal Abstinence Syndrome With Clonidine Versus Morphine as Primary Therapy

NCT03092011 is registered in ClinicalTrials.gov with The Cooper Health System as lead sponsor.

NCT NCT03092011
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03092011 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Neonatal Abstinence Syndrome With Clonidine Versus Morphine as Primary Therapy
Lead sponsor
The Cooper Health System
Phase
Phase 4
Overall status
Active, not recruiting
Start date
February 21, 2018
Completion date
December 1, 2026
Enrollment
69 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neonatal abstinence syndrome